Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

SensoDetect

0.17 SEK

-28.90 %

Less than 1K followers

SDET

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-28.90 %
-68.45 %
-74.62 %
-32.60 %
-24.78 %
-29.20 %
-28.17 %
-57.91 %
-96.24 %

SensoDetect operates in the healthcare sector. The company specializes in developing medical equipment that is used to analyze how a patient's brain reacts to sound stimuli. The technology is used in psychiatry to distinguish potential mental illnesses. The product consists of electrodes that are attached to the patient's head and then analyze brain activity. The results are compared against a database for further analysis. SensoDetect was founded in 2005 and is headquartered in Lund.

Read more
Market cap
74.51M SEK
Turnover
1.86M SEK
Revenue
100K
EBIT %
-9,740 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
20/2
2026

Annual report '25

22/5
2026

General meeting '26

All
Press releases
ShowingAll content types
Regulatory press release11/27/2025, 7:30 AM

SensoDetect AB avger delårsrapport perioden 2025 07 01 till 2025 09 30

SensoDetect
Regulatory press release11/26/2025, 9:44 AM

SensoDetect AB: SensoDetect addresses recent share-price volatility and reaffirms accelerating execution, market positioning and strategic financial direction

SensoDetect
Regulatory press release11/25/2025, 7:18 AM

SensoDetect AB: SensoDetect strengthens China execution with expert leadership, new and existing collaborations and AI-focused prototype.

SensoDetect

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release11/24/2025, 10:39 AM

SensoDetect AB: SensoDetect Advances Strategic Collaboration with Saudi Health Leadership to Integrate Objective Neurodevelopmental Screening Tools

SensoDetect
Regulatory press release11/14/2025, 12:07 PM

SensoDetect AB: Successful Presentation at Redeye Theme: Medtech & Diagnostics - Demonstrating the Global Rollout of Objective Neuro-Auditory Screening

SensoDetect
Regulatory press release11/11/2025, 7:45 AM

SensoDetect AB: SensoDetect to Present at Redeye Theme: Medtech & Diagnostics

SensoDetect
Regulatory press release11/10/2025, 3:45 PM

SensoDetect AB Announces Delegation Trip to China, 16-27 November 2025 and comments on delayed Q3 report

SensoDetect
Regulatory press release11/10/2025, 7:30 AM

SensoDetect AB: SensoDetect advances Middle East expansion - introduces strategy for private school screening programs and SensoDetect-owned screening centers

SensoDetect
Regulatory press release10/31/2025, 11:22 AM

SensoDetect AB Confirms receipt of license payments and announces successful installation and testing of AI software in China

SensoDetect
Regulatory press release10/31/2025, 10:01 AM

SensoDetect AB Announces Completion of Initial Investment Round for Beijing Mind Exploration Medical Technology Co., Ltd. (JV)

SensoDetect
Regulatory press release10/14/2025, 1:28 PM

Notification of Major Shareholding in SensoDetect AB

SensoDetect
Regulatory press release10/1/2025, 6:45 AM

SensoDetect AB: SensoDetect accelerates international collaborations to advance early screening and diagnostic support tools for Autism and ADHD

SensoDetect
Regulatory press release9/29/2025, 6:45 AM

SensoDetect AB: SensoDetect adds Dr Fatimah to its medical advisory board to boost data collection and drive autism study

SensoDetect
Regulatory press release9/26/2025, 6:45 AM

SensoDetect AB: SensoDetect accelerates international autism study and expands data collection to fuel next-generation algorithms

SensoDetect
Regulatory press release9/25/2025, 10:30 AM

SensoDetect AB: SensoDetect achieves AI breakthrough, unlocking scalable market leadership in neuropsychiatric diagnostics

SensoDetect
Regulatory press release9/23/2025, 12:24 PM

SensoDetect AB: Sensodetect embarks on strategic business mission to China and the Middle East: showcasing next-generation AI diagnostics and future ABR+ERP (EEG) technology roadmap to large investors

SensoDetect
Regulatory press release9/19/2025, 6:45 AM

SensoDetect AB: Sensodetect strengthens global clinical leadership: Dr. Mohamed Hussein Atwa Ahmed now permanently based in Sweden to drive expansion and investor value

SensoDetect
Regulatory press release9/5/2025, 1:57 PM

SensoDetect AB: Rapportkommentar SensoDetect Q2'25

SensoDetect
Regulatory press release8/29/2025, 3:30 PM

SensoDetect AB avger delårsrapport perioden 2025 04 01 till 2025 06 30

SensoDetect
Regulatory press release8/15/2025, 8:12 AM

SensoDetect AB: SensoDetects JV-bolag vinner första pris i kinesisk innovationstävling vilket accelererar bolagets kommersialisering på Kinas marknad för psykisk hälsa som värderas till över 1,3 miljarder dollar*.

SensoDetect
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.